May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Intravitreal Injection of Ketorolac Tromethamine in Postoperative Cystoid Macular Edema
Author Affiliations & Notes
  • M. K. Tsilimbaris
    Ophthalmology, University of Crete, Heraklion, Greece
  • T. D. Panagiotoglou
    Ophthalmology, University of Crete, Heraklion, Greece
  • C. Tsika
    Ophthalmology, University of Crete, Heraklion, Greece
  • V. Pandeleondidis
    Ophthalmology, University of Crete, Heraklion, Greece
  • G. Kymionis
    Ophthalmology, University of Crete, Heraklion, Greece
  • Footnotes
    Commercial Relationships  M.K. Tsilimbaris, None; T.D. Panagiotoglou, None; C. Tsika, None; V. Pandeleondidis, None; G. Kymionis, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 2693. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. K. Tsilimbaris, T. D. Panagiotoglou, C. Tsika, V. Pandeleondidis, G. Kymionis; Intravitreal Injection of Ketorolac Tromethamine in Postoperative Cystoid Macular Edema. Invest. Ophthalmol. Vis. Sci. 2008;49(13):2693. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : The aim of this pilot study is to investigate the effect of intravitreal administration of ketorolac tromethamine in post-operative cystoid macular edema.

Methods: : 5 patients diagnosed with post-operative cystoid macular edema were enrolled. 2 patients received 2 intravitreal injections of 300µg (0, 05 ml) of ketorolac tromethamine (Toradol), with a three-week interval, while 3 patients received 4 consecutive intravitreal injections of 500µg (0, 05 ml) weekly. Visual acuity assessment, tonometry, fundoscopy and optical coherence tomography (OCT) were performed prior to first injection and weekly for the following 5 weeks. Fluorescein angiography was performed before 1st injection and at 5th week period.

Results: : No adverse reactions were noticed in any patient. Analysis of data indicates a trend for improvement of visual acuity as well as regression of edema after initiation of therapy with rebound after week three in all patients.

Conclusions: : This pilot study indicates a possible role of intravitreal injection of ketorolac tromethamine in patients with postoperative cystoid macular edema. Further research is warranted in order to obtain conclusive results concerning doses and timing of injections.

Keywords: edema • macula/fovea • drug toxicity/drug effects 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×